Net Loss per Common Share (Tables)

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Schedule of Anti-Dilutive Securities Excluded from Computations of Diluted Weighted-Average Shares

The following potentially dilutive securities have been excluded from the computations of diluted weighted-average shares outstanding for the periods presented, as they would be anti-dilutive:

	For the Three Months Ended March 31,
	2021		2022
Common warrants outstanding		991,863		857,261
RSUs outstanding		36		36
Convertible preferred stock outstanding (number of common stock equivalents)		46,651		46,136
Common options outstanding		1,213,284		3,203,514
Total anti-dilutive common share equivalents		2,251,834		4,106,947